Overview

A Study of Peldesine (BCX-34) in HIV-Infected Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the highest amount of peldesine that is safe. This study will also see if this amount of peldesine is effective in lowering HIV levels in the blood.
Phase:
Phase 1
Details
Lead Sponsor:
BioCryst Pharmaceuticals